Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,280 | -5,610 | -2,810 | -1,350 | -3,050 |
| Depreciation Amortization | 10 | 7 | 4 | 2 | 3 |
| Other Working Capital | 1,210 | 930 | 570 | 370 | -180 |
| Other Operating Activity | 600 | 473 | 346 | 228 | 837 |
| Operating Cash Flow | $-6,460 | $-4,200 | $-1,890 | $-750 | $-2,390 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -10 | -3 | -2 | -20 |
| Other Investing Activity | -1,430 | -1,990 | 13 | 22 | -230 |
| Investing Cash Flow | $-1,440 | $-2,000 | $10 | $20 | $-250 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -260 | -190 | -130 | -60 | 0 |
| Other Financing Activity | 13,840 | 13,840 | 13,840 | 13,880 | 6,900 |
| Financing Cash Flow | $13,580 | $13,650 | $13,710 | $13,820 | $6,900 |
| Beginning Cash Position | 4,260 | 4,260 | 4,260 | 4,260 | 10 |
| End Cash Position | 9,930 | 11,710 | 16,110 | 17,360 | 4,260 |
| Net Cash Flow | $5,670 | $7,440 | $11,840 | $13,090 | $4,250 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,460 | -4,200 | -1,890 | -750 | -2,390 |
| Free Cash Flow | -6,460 | -4,200 | -1,890 | -750 | -2,390 |